4
Changes in Ownership
Xenon Pharmaceuticals Inc. Filed Acc 0001209191-19-050136
Director sold 9,437 shares at an average $9.30 ($87,778)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| HOLLER FRANK A Director | 2019-09-17 | Sale | −5,069 | $9.32 | $47,243 | 136,129 | D |
| HOLLER FRANK A Director | 2019-09-18 | Sale | −4,368 | $9.28 | $40,535 | 131,761 | D |
| Derivatives | |||||||
| HOLLER FRANK A Director | 2019-09-16 | Grant or award · Stock Option (Right to Buy) | +15,000 | 15,000 | D | ||
| Open-market sales · 9,437 sh · avg $9.30 · $87,778 | |||||||
Loading xslF345X03/doc4.xml…